ASH Action Center
Welcome to the ASH Action Center, bringing you the latest updates from the annual American Society of Hematology (ASH) Meeting and Exposition. This collection features expert and scientific insights from the conference that highlight key strategies and research on the hottest topics in hematology.
1-15 of 17
Tracking Lineage Infidelity in Pediatric B-ALL: New Insights From ASH
Project Oncology®Tracking Lineage Infidelity in Pediatric B-ALL: New Insights From ASH
Ryan Quigley
Kathrin M. Bernt, MD
Rushabh Mehta, BS
Fatemeh Alikarami
Beyond the Cure: Addressing Psychosocial Needs in Gene Therapy for SCD
Project Oncology®Beyond the Cure: Addressing Psychosocial Needs in Gene Therapy for SCD
Victoria Coleman-Cowger, PhD
CLL17 Trial Insights: Fixed-Duration vs Continuous Therapy in Frontline CLL
Project Oncology®CLL17 Trial Insights: Fixed-Duration vs Continuous Therapy in Frontline CLL
Ryan Quigley
Predicting Prognosis in DLBCL: The Role of Immune-Related Gene Signatures
Project Oncology®Predicting Prognosis in DLBCL: The Role of Immune-Related Gene Signatures
Relapsed or Refractory DLBCL: Reviewing the Expanding Treatment Landscape
Project Oncology®Relapsed or Refractory DLBCL: Reviewing the Expanding Treatment Landscape
Treating R/R Classic Hodgkin Lymphoma: Ipilimumab and Other Approaches
Project Oncology®Treating R/R Classic Hodgkin Lymphoma: Ipilimumab and Other Approaches
- advertisement
Understanding Heparin Resistance: Underlying Mechanisms and Alternative Treatment Options
Project Oncology®Understanding Heparin Resistance: Underlying Mechanisms and Alternative Treatment Options
Cheryl Maier MD, PhD
Michael Gonzalez, PhD, MSc
The Future of ITP Care: Exploring New Treatments
Project Oncology®The Future of ITP Care: Exploring New Treatments
Michele Lambert, MD, MSTR
Diagnosing Castleman Disease: Key Considerations
Project Oncology®Diagnosing Castleman Disease: Key Considerations
Mateo Bustamante
Improving Diagnosis of Castleman Disease: The Key Role of Stromal Cells
Project Oncology®Improving Diagnosis of Castleman Disease: The Key Role of Stromal Cells
Joshua Brandstadter, MD, PhD, MSc
How Socioeconomic Disparities Affect Outcomes Among Burkitt Lymphoma Patients
ASH Action CenterHow Socioeconomic Disparities Affect Outcomes Among Burkitt Lymphoma Patients
- advertisement
Immune Thrombocytopenia: Key Clinical Data on Cognitive Impairment
ASH Action CenterImmune Thrombocytopenia: Key Clinical Data on Cognitive Impairment
Updates on Sickle Cell Disease From ASH: A Hematologist’s Perspective
ASH Action CenterUpdates on Sickle Cell Disease From ASH: A Hematologist’s Perspective
Charles Turck, PharmD, BCPS, BCCCP
Clifford Takemoto, MD
Updates in SCD: Posters from the 64th ASH Annual Meeting
ASH Action CenterUpdates in SCD: Posters from the 64th ASH Annual Meeting